- Tytuł:
- Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab.
- Autorzy:
- Źródło:
- PloS one [PLoS One] 2024 Feb 01; Vol. 19 (2), pp. e0293264. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
- Typ publikacji:
- Journal Article
- MeSH Terms:
-
Drug Costs *
Neoplasms*/drug therapy
Antibodies, Monoclonal, Humanized*
Humans ; Antibodies, Monoclonal/therapeutic use ; Cost Control
Czasopismo naukowe